Correlation Between Esperion Therapeutics and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and TC BioPharm Holdings, you can compare the effects of market volatilities on Esperion Therapeutics and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and TC BioPharm.

Diversification Opportunities for Esperion Therapeutics and TC BioPharm

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Esperion and TCBP is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and TC BioPharm go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and TC BioPharm

Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 0.39 times more return on investment than TC BioPharm. However, Esperion Therapeutics is 2.55 times less risky than TC BioPharm. It trades about 0.2 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.39 per unit of risk. If you would invest  196.00  in Esperion Therapeutics on September 3, 2024 and sell it today you would earn a total of  84.00  from holding Esperion Therapeutics or generate 42.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Esperion Therapeutics  vs.  TC BioPharm Holdings

 Performance 
       Timeline  
Esperion Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
TC BioPharm Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Esperion Therapeutics and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Esperion Therapeutics and TC BioPharm

The main advantage of trading using opposite Esperion Therapeutics and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Esperion Therapeutics and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing